<?xml version = '1.0' encoding = 'UTF-8'?><DATASETS>
   <DATASET alias="WGSeq_RNAseq_ChIPseq_Cancer_ICGC_DATA_SET_xmas_MB_2013_07_10" center_name="DKFZ-IBIOS" accession="EGAD00001000664" broker_name="EGA" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
      <IDENTIFIERS>
         <PRIMARY_ID>EGAD00001000664</PRIMARY_ID>
         <SUBMITTER_ID namespace="DKFZ-IBIOS">WGSeq_RNAseq_ChIPseq_Cancer_ICGC_DATA_SET_xmas_MB_2013_07_10</SUBMITTER_ID>
      </IDENTIFIERS>
      <TITLE>Whole Genome, RNA, and ChIP Sequencing of matched brain tumor-normal pairs (ICGC)</TITLE>
      <DESCRIPTION>Whole Genome Seq: Illumina HiSeq sequence data (with >30x coverage) were aligned to the hg19 human reference genome assembly using BWA (Li and Durbin, 2009);
duplicate reads were removed from the final BAM file. No realignment or recalibration was performed. Paired-end RNA sequencing reads were mapped to the hg19 assembly of the human reference genome using BWA.
Each ChIP-seq library was sequenced with two complete lanes on the Illumina HiSeq 2500 in the 101-bases paired-end rapid mode and aligned to hg19 using bwa.
This resulted in the following coverage values (genome-wide, after deduplication, including all uniquely mapping reads):
GBM103  macroH2A1: 17x   H3K36me3: 20x
MB59    macroH2A1: 11x   H3K36me3: 11x</DESCRIPTION>
      <ANALYSIS_REF accession="EGAZ00001015227" refname="ANALYSIS_RNA-Seq_ICGC_MB59">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015227</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_RNA-Seq_ICGC_MB59</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015228" refname="ANALYSIS_WGS_ICGC_MB59">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015228</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_WGS_ICGC_MB59</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015224" refname="ANALYSIS_WGS_ICGC_BL59">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015224</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_WGS_ICGC_BL59</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015226" refname="ANALYSIS_ChIP-Seq_ICGC_MB59_2">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015226</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_ChIP-Seq_ICGC_MB59_2</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015225" refname="ANALYSIS_ChIP-Seq_ICGC_MB59_1">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015225</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_ChIP-Seq_ICGC_MB59_1</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015217" refname="ANALYSIS_WGS_GBM103_tumor_glioblastoma">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015217</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_WGS_GBM103_tumor_glioblastoma</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015213" refname="ANALYSIS_WGS_GBM103_blood">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015213</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_WGS_GBM103_blood</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015215" refname="ANALYSIS_ChIP-Seq_GBM103_macroH2A_tumor">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015215</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_ChIP-Seq_GBM103_macroH2A_tumor</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015214" refname="ANALYSIS_ChIP-Seq_GBM103_H3K36me3_tumor">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015214</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_ChIP-Seq_GBM103_H3K36me3_tumor</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <ANALYSIS_REF accession="EGAZ00001015216" refname="ANALYSIS_RNA-Seq_GBM103_RNA_tumor">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAZ00001015216</PRIMARY_ID>
            <SUBMITTER_ID namespace="">ANALYSIS_RNA-Seq_GBM103_RNA_tumor</SUBMITTER_ID>
         </IDENTIFIERS>
      </ANALYSIS_REF>
      <POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
         <IDENTIFIERS>
            <PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
            <SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
         </IDENTIFIERS>
      </POLICY_REF>
      <DATASET_LINKS>
         <DATASET_LINK>
            <URL_LINK>
               <LABEL>ICGC Data Portal</LABEL>
               <URL>http://dcc.icgc.org</URL>
            </URL_LINK>
         </DATASET_LINK>
      </DATASET_LINKS>
   </DATASET>
</DATASETS>